MetaTOC stay on top of your field, easily

Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn’s disease

, , , , , , ,

Therapeutic Advances in Gastroenterology

Published online on

Abstract

Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:The vedolizumab-specific clinical decision support tool (VDZ-CDST) was developed to predict the probability of a response to vedolizumab treatment in patients with Crohn’s disease (CD).Objective:This post hoc analysis aimed to characterize the ...